Clinical Trials Browser

OTHER × Depression × Melatonin × Clear all

NCT05474846 2025-11-06

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

Phase 2/3 Recruiting

Anxiety Disorders, Depression, Fatigue, Neoplasms

NCT03205033 2017-07-02

Melatonin as a Circadian Clock Regulator, Neuromodulator and Myelo-protector in Adjuvant Breast Cancer Chemotherapy

Phase 2 Completed

Breast Neoplasms, Depression, Pain, Sleep Disorders, Circadian Rhythm

NCT01355523 2014-05-06

MELODY

Phase 2/3 Terminated

54 enrolled 27 charts

Anxiety Disorders, Breast Neoplasms, Depression, Parasomnias